6ML vs BANB: Side-by-Side Comparison
Compare MOLECULAR PARTNERS SF 1 (6ML) and Bachem Holding AG (BANB) side by side: market cap EUR 126.79M vs CHF 5.67B. Financials, growth and model signals on Bullrun.
| Metric | 6ML | BANB |
|---|---|---|
| Company | MOLECULAR PARTNERS SF 1 | Bachem Holding AG |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 126.79M | CHF 5.67B |
| P/E ratio | — | 38.2 |
| Dividend yield | — | 1.23% |
| Valuation model | — | — |
| Revenue (latest FY) | — | CHF 695.07M |
| Revenue growth YoY | — | +14.8% |
| Net income | — | CHF 148.79M |
| Gross margin | — | 28.7% |
| Diluted EPS | — | 1.98 |